What Comes Next: The Cost of Intelligence & The 2027 Payer Cliff

“With Google and all its competitors now, they’re laying out hundreds of billions of dollars. That’s real money. That kind of money wasn’t even put in the railroad business. And that’s the game they’re playing now. They weren’t playing that game with computer software.”

Warren Buffett, longtime CEO, Berkshire Hathaway. CNBC, July 2026.

The AI trade, scored, technology names only. Market value on Oct 14, 2022, the bear-market low just before ChatGPT, against Aug 5, 2026. The picks and shovels of AI infrastructure multiplied. The software names the market later turned on tell the other half of the story.

Change reflects market value from Oct 14, 2022 to Aug 5, 2026. Values rounded, current as of Aug 5, 2026. Winners are AI infrastructure names; losers are software franchises the market has repriced as AI shifts from tailwind to threat.

One thing about AI is settled: people are using more of it. What it will cost is not. Open models keep pushing the price of a token down, while surging demand and constrained supply of compute, power, and chips push the total bill up. Healthcare is where those two forces meet.

The Wall Street Journal reports OpenAI missed several monthly revenue targets this year as Anthropic pulled ahead in coding and enterprise. Claude reportedly holds about 42% of code generation share to OpenAI’s 21%. Enterprise demand keeps climbing. For health systems, the vendor pecking order is shifting fast. WSJ

Alibaba unveiled Qwen 3.8-MAX, a 2.4-trillion-parameter model with lower inference costs and open weights arriving next week. Alibaba claims it beats OpenAI and Anthropic on several coding and multimodal benchmarks. Cheaper, open models push the price of intelligence down, the counterweight to rising compute bills. Investing.com

AI tokens have become a real line item in hospital budgets. Systems must decide how much inference to buy: overprovision and overpay, underbuy and throttle clinical tools. As ambient scribes and agents scale, Becker’s reports leaders scrambling to right-size spend on a unit most never budgeted for. Becker’s

While Wall Street rewards AI infrastructure, healthcare’s own capital is chasing the front door to the patient. Buy the physical points of access, fund the digital ones. But as the new rankings remind us, capital buys scale and access, not reputation.

HCA acquired Texas MedClinic on Aug. 1, splitting the 40-center network between its Methodist and St. David’s systems. St. David’s rebrands 14 clinics as CareNow. The deal follows 17 Carolina clinics in June and 13 in February, a low-cost front door to its hospitals. Becker’s

Function Health closed a $450M growth round from General Catalyst’s Customer Value Fund, eight months after a $298M Series B, passing $800M raised since 2023. Membership runs $365 a year for 160-plus lab tests and imaging. Consumer diagnostics is becoming a capital-rich entry point to care. Digital Health Funding

U.S. News named its 2026-27 Best Hospitals Honor Roll, and Mayo Clinic placed three campuses: Rochester, Jacksonville, and Phoenix. Absent are healthcare’s largest operators by hospital count: HCA (190), Ascension (119), Tenet (50), and Kaiser (40). The systems buying the most scale still cannot buy clinical prestige. U.S. News (via FOX 9)

Insurers are having a good quarter, but not because care got cheaper. Q2 profits came from exiting markets, cutting benefits, and raising premiums. The ACA is the fault line running through every earnings call, and 2027 looks harder.

Health insurers beat Q2 estimates and raised full-year guidance, reversing last year’s cost shocks. The gains came from market exits, benefit cuts, and premium hikes, not lower costs. Payers signal more increases and exits for 2027 as ACA enrollment falls, the risk pool worsens, and Medicaid cuts loom. Healthcare Brew

Changes to the ACA hit payers and for-profit systems alike in Q2. Centene’s exchange membership fell over 2 million, Cigna will exit ACA marketplaces in 2027, and HCA cited a $1B-plus ACA headwind while cutting guidance. Results split: Tenet and Elevance raised outlooks, others trimmed. Becker’s Payer

Medicare Market Insights compared seven publicly traded carriers side by side for Q2 2026. Consolidated operating profit rose 57% while total membership fell 1%. UnitedHealth and CVS grew operating income 55% and 98% even as Medicare Advantage rolls shrank. Carriers are cutting to profit, with more exits expected in 2027. Medicare Market Insights